We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go: 14 investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Perspective Pictures is a creative, digital-first video production company based in North London.
days to go: Expired investment: £151,457
KogoPAY is a start-up fintech mobile payment company which offers quick, simple and economic regional & global money transfer with the help of an application. The company has a UK FCA licence, and it is on the last step for EU EMI licence. KogoPay has 1000 customers signed up and has been chosen to join the Mayor of London Business & Partners Accelerator. The company is planning to use the funds to complete rollout over Europe and Asia and to invest in advanced performance and customer service using Artificial Intelligence.

Pitch Rated

74%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £198,620
An IT recruitment and training site launched to meet the demands of enterprises that require highly skilled tech professionals. 365 Talent Portal offers companies to hire IT consultants at a lower price compared to traditional recruitment hubs. The company also allows IT professionals registered on the site to access training and certification programmes that will expand their current skillset and become more marketable to potential employers. 365 Talent Portal is raising funds to produce more prominent marketing campaigns and establish their brand in major markets such as the USA. In addition to this, the company will be using AI more heavily and develop a more automated approach on their platform for their customers.
days to go: Expired investment: £156,000
Nebeus aims to bridge the gap between cryptocurrency and cash, providing people with instant crypto-backed cash services for everyday use. The company argues that there is an equivalent of $400 billion held in more than 55 million crypto wallets around the world which cannot be used further than keeping as an investment. It aims to change this scenario. Nebeus's core product is its 'Instant Loans' offering. It also offers users to do mobile top-ups, conduct Card2Card transfers, and send cash to Points of Sale (PoS) amongst other financial services. The company is working to come out with a 'Nebeus Mastercard' in partnership with Railsbank in Q1 of 2021. Nebeus has more than 60,000 users on its portal and has overseen transactions over £30 million to date. The company has featured in publications like The Independent, Forbes, and Bloomberg to name a few. It will use the investment for growth and marketing, the rollout of Nebeus Mastercard rollout, for growing its team, and for Research and Development (R&D).
days to go: Expired investment: £862,580
Killing Kittens is a female empowerment brand that is leading a global movement to promote positivity for women, men and couples of all ages and sexualities. Its social media application has around 140,000 members worldwide, and the brand has hosted events in 12 countries. Killing Kitten's members use this platform to connect with like-minded people, improve their sex lives through education, and engage with brands and content. The company has raised £1 million in two previous successful funding rounds. In this round, 45% of the investment will be used for marketing, 45% for product innovation, 5% for preparing for funding, and 5% for operations.
days to go: Expired investment: £340,930
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph